Degenerate Hessian structures on radiant manifolds

Autor: García-Ariza, M. Á.

Publikováno v: Int. J. Geom. Methods Mod. Phys. 15 (2018) 1850087

We present a rigorous mathematical treatment of Ruppeiner geometry, by considering degenerate Hessian metrics defined on radiant manifolds. A manifold $M$ is said to be radiant if it is endowed with a symmetric, flat connection $\bar\nabla$ and a glo

Externí odkaz: http://arxiv.org/abs/1503.00689

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.

Autor: Goddard J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Castle J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Southworth E; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Fletcher A; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Crosier S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Martin-Guerrero I; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, Spain., García-Ariza M; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Pediatric Hematology and Oncology, Cruces University Hospital, Barakaldo, Spain., Navajas A; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Masliah-Planchon J; Unité de Génétique Somatique, Institut Curie, Paris, France., Bourdeaut F; SIREDO Pediatric Oncology Center, Curie Institute, Paris, France., Dufour C; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Rue Edouard Vaillant, 94805, Villejuif, France., Ayrault O; UMR 3347, INSERM U1021, Institut Curie, PSL Research University, Université Paris Sud, Université Paris-Saclay, CNRS, Paris, France., Goschzik T; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany., Pietsch T; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany., Sill M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Paediatric Haematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richardson S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Hill RM; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Williamson D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Bailey S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Schwalbe EC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne, UK., Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. steve.clifford@ncl.ac.uk., Hicks D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. debbie.hicks@newcastle.ac.uk.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2023 May; Vol. 145 (5), pp. 651-666. Date of Electronic Publication: 2023 Apr 04.

Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma.

Autor: Alaña L; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain., Nunes-Xavier CE; Biomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0310 Oslo, Norway., Zaldumbide L; Department of Pathology, Hospital Universitario de Cruces, Osakidetza, Plaza de Cruces 12, 48903 Barakaldo, Spain., Martin-Guerrero I; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Department of Genetics, Physical Anthropology and Animal Pathology, Faculty of Science and Technology, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain., Mosteiro L; Department of Pathology, Hospital Universitario de Cruces, Osakidetza, Plaza de Cruces 12, 48903 Barakaldo, Spain., Alba-Pavón P; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain., Villate O; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain., García-Obregón S; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Department of Physiology, Faculty of Medicine and Nursing, Campus de Leioa, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain., González-García H; Oncohematology Pediatric Unit, Department of Pediatrics, Hospital Universitario de Valladolid, C/Ramon y Cajal n°3, 47003 Valladolid, Spain., Herraiz R; Oncohematology Pediatric Unit, Department of Pediatrics, Hospital Universitario de Valladolid, C/Ramon y Cajal n°3, 47003 Valladolid, Spain., Astigarraga I; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Pediatric Oncohematology Unit, Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Pediatrics Department, Faculty of Medicine and Nursing, University of the Basque Country, UPV/EHU, Plaza de Cruces 12, 48903 Barakaldo, Spain., Pulido R; Biomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain., García-Ariza M; Pediatric Oncology Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Pediatric Oncohematology Unit, Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Plaza de Cruces 12, 48903 Barakaldo, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2022 Jan 14; Vol. 14 (2). Date of Electronic Publication: 2022 Jan 14.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1407 - Prophylaxis and therapy of tumor lysis syndrome in 115 pediatric patients diagnosed with hematological neoplasms

Autor: Astigarraga, I., Garcia-Obregon, S., Capape, S., Ortiz-Calahorro, J., Fernandez-Bernal, M., Pena, A., Garcia-Orad, A., Martin-Guerrero, I., Gutierrez-Camino, A., Gil-Lemus, M.A., Pilar-Orive, J., Adan, R., Lopez-Almaraz, R., Garcia-Ariza, M., Echebarria, A.

Publikováno v: In European Journal of Cancer February 2017 72 Supplement 1:S147-S147